Key result
Inhibitors of signalling cascade enzymes showed the same effect on ROS production and elastase release in human neutrophils, except staurosporine, which inhibited chemiluminescence but increased elastase release.
Why the study?
This study was undertaken to compare intracellular signalling pathways that lead to reactive oxygen species production and degranulation of azurophilic granules in human fMet-Leu-Phe/cytochalasin B stimulated neutrophils.
Do inhibitors of intracellular signalling cascades affect reactive oxygen species production and degranulation of azurophilic granules in human fMet-Leu-Phe/cytochalasin B stimulated neutrophils?
Do inhibitors of intracellular signalling cascades affect reactive oxygen species production and degranulation of azurophilic granules in human fMet-Leu-Phe/cytochalasin B stimulated neutrophils?
Early intracellular signalling pathways leading to reactive oxygen species production and azurophilic granule degranulation are shared in human neutrophils, likely branching at the point of phosphatidic acid production by phospholipase D.
BACKGROUND/AIM: Polymorphonuclear leukocytes (neutrophils) release a variety of toxic agents--proteins and reactive oxygen species (ROS)--that are used to inactivate foreign microorganisms in the non-specific immune response. This study was undertaken to compare intracellular signalling pathways that lead to the ROS production as well as degranulation of azurophilic granules of human fMet-Leu-Phe/cytochalasin B stimulated neutrophils. METHODS: Luminol-amplified chemiluminescence was used for monitoring the oxidative activity of human neutrophils in the presence of various inhibitors. The elastase activity was assessed in the neutrophil supernatant as a marker for degranulation of azurophilic granules. RESULTS: Tested inhibitors of enzymes of signalling cascades showed the same effect on the ROS production and on the activity of elastase released from neutrophils. The only difference was obtained with staurosporine: it inhibited the chemiluminescence response, but increased the elastase release. CONCLUSION: Early signalling pathways leading to the ROS production and the degranulation are ubiquitous in human neutrophils. They are branching most probably at the point of the phosphatidic acid production by phospholipase D. A protein kinase activated by this lipid second messenger might play a central regulatory role in human neutrophils.
No takes yet. Share an insight, caveat, or question.
Sinitsyna et al. (2026) studied this question. Signalling cascade enzyme inhibitors (including staurosporine) was evaluated on Reactive oxygen species (ROS) production and elastase activity (degranulation of azurophilic granules). Inhibitors of signalling cascade enzymes showed the same effect on ROS production and elastase release in human neutrophils, except staurosporine, which inhibited chemiluminescence but increased elastase release.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: